Diversify Advisory Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Buy
12,005
+9,371
+356% +$1.76M 0.03% 405
2026
Q1
$488K Sell
2,634
-8,291
-76% -$1.6M 0.07% 118
2025
Q4
$2.06M Buy
10,925
+544
+5% +$95.4K 0.07% 222
2025
Q3
$1.7M Sell
10,381
-1,522
-13% -$230K 0.06% 241
2025
Q2
$1.79M Buy
11,903
+1,213
+11% +$170K 0.07% 204
2025
Q1
$1.53M Buy
10,690
+4,646
+77% +$672K 0.1% 147
2024
Q4
$810K Sell
6,044
-1,841
-23% -$258K 0.04% 261
2024
Q3
$1.22M Buy
7,885
+111
+1% +$17.9K 0.07% 228
2024
Q2
$1.19M Buy
7,774
+1,560
+25% +$235K 0.07% 211
2024
Q1
$836K Buy
+6,214
New +$823K 0.05% 298

Other funds holding AZN

Diversify Advisory Services's AZN Position: Q2 2026 in Review

Diversify Advisory Services increased its AstraZeneca (AZN) stake by 356% in Q2 2026, buying an estimated $1.76M and bringing the position to 12,005 shares worth $2.04M. The position accounts for 0.03% of the portfolio, ranked #405.

Diversify Advisory Services first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.06M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Diversify Advisory Services held 12,005 shares of AstraZeneca worth $2.04M as of Q2 2026.
  • Diversify Advisory Services bought 9,371 AstraZeneca shares in Q2 2026, an estimated $1.76M.
  • AstraZeneca made up 0.03% of Diversify Advisory Services's portfolio in Q2 2026, its #405 holding.
  • Diversify Advisory Services first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
  • Diversify Advisory Services's AstraZeneca position peaked at $2.06M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.